immunotherapy

Events

Partner Content

Immuno-Oncology

Immuno-Oncology Main Conference: 26 – 27 September 2018 Pre-Conference Workshops: 25 September 2018 Copthorne Tara Hotel, London, UK

News

Merck shows canny cancer strategy in $5.76bn Eisai milestone...

Firms will co-develop Lenvima and Keytruda combinations

News

Immunotherapy arms race latest: Merck buys Viralytics for $3...

Big pharma pays 160% premium for Australian biotech

News

Groundbreaking lung cancer approval a big boost for AZ's Imf...

AstraZeneca’s immunotherapy Imfinzi has gained US approval in an important new earlier treatment setting for lung cancer patients.

News

Radiology technician examens mammography test on location

Syndax announces further entinostat collaboration with Roche

Syndax Pharmaceuticals has announced a new collaboration with Roche’s Genentech unit dedicated to combining small molecule cancer drug entinostat with the latter’s immunotherapy, Tecentriq.

Events

Partner Content

3rd International Conference on Pancreatic Cancer and Liver ...

Making Life Better: Fight Against Pancreatic Cancer

Immuno-Oncology

Merck shows canny cancer strategy in $5.76bn Eisai milestone...

Immunotherapy arms race latest: Merck buys Viralytics for $3...

Groundbreaking lung cancer approval a big boost for AZ's Imf...

Syndax announces further entinostat collaboration with Roche

3rd International Conference on Pancreatic Cancer and Liver ...

LSX2026: Addressing adult eye cancer, with Roi Raz

Using AI-driven synthetic personas to take your insights fur...

immunotherapy

Editor's Picks